Core Viewpoint - The article summarizes significant changes in research ratings from various institutions, highlighting potential investment opportunities and risks for investors in the market [1][5]. Upgraded Ratings - Arete upgraded Spotify (SPOT) from Neutral to Buy with a target price of $586, citing improving gross margins in its paid membership business and minimal risk from AI disruption [6]. - TD Cowen raised Nasdaq (NDAQ) rating from Hold to Buy, increasing the target price from $105 to $106, due to recent stock price pullback and increased confidence in the sustainability of its platform, especially in the fintech sector [6]. - Wells Fargo upgraded Alcon (ALC) from Equal Weight to Overweight, raising the target price from $88 to $97, believing there is upside potential in its 2026 earnings guidance as a new product cycle begins to drive growth [6]. - H.C. Wainwright upgraded Joby Aviation (JOBY) from Neutral to Buy with a target price of $18, as the company progresses towards final certification [6]. - Trust Bank upgraded U.S. Bancorp (USB) from Hold to Buy, increasing the target price from $61 to $66, citing completed transformation, improved net interest margins, and enhanced balance sheet flexibility [6]. Downgraded Ratings - Deutsche Bank downgraded First Solar (FSLR) from Buy to Hold, lowering the target price from $300 to $245, due to a challenging market environment and tariff impacts on shipments from India [6]. - Loop Capital downgraded The Trade Desk (TTD) from Buy to Hold, reducing the target price from $75 to $25, despite exceeding fourth-quarter expectations, as the 2026 guidance fell short [6]. - Bank of America downgraded Oddity (ODD) from Buy to Underperform, drastically lowering the target price from $58 to $10, due to significant challenges in new user acquisition and a 30% decline in first-quarter revenue guidance [6]. - JPMorgan downgraded Mosaic (MOS) from Neutral to Underweight, maintaining a target price of $24, anticipating lower earnings in 2026 [6]. - Citizens downgraded C3 AI (AI) from Outperform to Market Perform, citing disappointing third-quarter results [6]. Initiated Coverage - Keefe Bruyette & Woods initiated coverage on Five Below (FIVE) with an Outperform rating and a target price of $267 [6]. - William Blair initiated coverage on Builders FirstSource (BLDR) with an Outperform rating, optimistic about benefiting from a housing market recovery and potential 50% upside in stock price [6]. - Wedbush initiated coverage on Eikon Therapeutics (EIKN) with an Underperform rating and a target price of $7, citing significant clinical risks and expensive valuations [6].